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The Multidimensional Anxiety Scale for Children (MASC): Confirmatory factor 
analysis in a pediatric ADHD sample 
J.S. March, C. Conners, G. Arnold, J. Epstein, J. Parker, S. Hinshaw, H. Abikoff, B. 
Molina, K. Wells, J. Newcorn, S. Schuck, W.E. Pelham, B. Hoza 
While considerable attention has been paid to discriminating attention-deficit/hyperactivity and anxiety 
disorders, there are as yet no published confirmatory factor analytic studies of any self-report anxiety scale 
in ADHD youth. The Multidimensional Anxiety Scale for Children (MASC) is a 39-item, 4-point Likert 
self-report scale that robustly represents the factor structure of anxiety in children aged 8 to 18 years. Using 
confirmatory factor analytic methods, the present paper reports a replication of the four-factor measurement 
model for the MASC in a large sample of ADHD youth aged 7 to 10 years. The fit indices proved to be 
comparable to those obtained in the MASC clinical and non-clinical (normative) samples. Clinically, 
therefore, this report strengthens confidence that the MASC is a valid measure of anxiety in diverse 
populations. With respect to research, it provides supporting evidence that results obtained using the 
MASC in the MTA and other research studies reflect valid estimates of anxiety in those samples. 
Presumably because pathological anxiety is associated with significant suffering, 
disruption in normal psychosocial and academic development and family functioning, and 
increased utilization of medical services, "worry" is among the more common causes of referral 
to children's mental health care providers (Black, 1995; Simon, Ormel, VonKorff, & Barlow, 
1995). Nonetheless, the prevalence of childhood-onset fears in the population, the structure of 
anxiety symptoms in the general pediatric population, and the relative importance of specific 
anxiety dimensions within gender, ethnic, cultural, or neuropsychiatric disorder-based groupings 
has remained unclear, in part because of a lack of acceptable measurement tools (Costello & 
Angold, 1995; Last, Perrin, Hersen, & Kazdin, 1992). 
We recently described the development and preliminary factor structure of the 
Multidimensional Anxiety Scale for Children (MASC), which rectifies problems found with 
older instruments (March & Parker, in press; March, Parker, Sullivan, Stallings, & Conners, 
1997a). The MASC is a 39-item, 4-point, Likert self-report scale, which has undergone extensive 
psychometric evaluation (March, 1998). The MASC main and subfactors include the following: 
(1) physical symptoms (tense/restless and somatic/autonomic), (2) social anxiety 
(humiliation/rejection and public performance fears), (3) harm avoidance (anxious coping and 
perfectionism) and (4) separation anxiety. The MASC contains two other empirically-derived 
subscales: (1) a 10-item unifactorial short form (MASC-10) intended for use in epidemiological 
and treatment outcome studies, and (2) a 12-item anxiety disorder index with a high degree of 
diagnostic efficiency (March, 1998). The Internal reliability and test-retest reliability for the 
MASC total score and all the factors and subfactors are in the satisfactory to excellent range 
(March et al., 1997a; March, Sullivan, & Parker, in press). 
A series of confirmatory factor analyses have been conducted for the four-factor MASC 
across multiple normal and psychopathological groupings (March, 1998). In the initial study, the 
four-factor model for the 39-item MASC met the criteria standards for adequacy of fit (Bentler, 
1988) in both school-based population and clinical psychiatric samples March, 1998). 
Subsequently, separate multi-sample confirmatory factor analyses were conducted to test whether 
the four-factor MASC was equivalent for males and females and for two age-groups: 12 years 
old and under and 13 years old and over. Multiple goodness-of-fit indicators revealed that the 
four-factor model fit well for both age-groups and both genders. Using gender as the exemplar, 
the non-normed fit index (NNFI, Bentler & Bonnett, 1980) was 0.913, the comparative fit index 
(CFI, Bentler, 1988) was 0.916, and the incremental fit index (IFI, Bolen, 1989) was 0.917. 
Similar analyses demonstrated that the MASC factor structure was identical in white and black 
youth (March, 1998). The overall conclusion to be drawn is that the MASC factor structure is 
identical across these diverse samples of children and adolescents. 
Unlike the RCMAS, which differentiates children with DSM-III-R anxiety and 
attention-deficit disorders from normals but not from each other (Perrin & Last, 1992), the MASC 
shows reasonably robust discriminant validity for both ADHD and depression (March, Parker, 
Sullivan, Stallings, & Conners, 1997b). For example, in a series of analyses using discriminant 
function analysis, an empirically derived Anxiety Index was used to predict group membership 
in children and adolescents aged 8 to 18 years with anxiety disorders versus age- and 
gender-matched normal and ADHD comparison groups. With normals, the overall correct 
classification rate was an excellent 95 percent. Not surprisingly, discriminating anxiety from 
ADHD is a much more difficult problem psychometrically than discriminating between subjects 
with and without clinical symptoms (Perrin & Last, 1992). Nonetheless, the MASC Anxiety 
Index performs in the satisfactory range. Specifically, in an age- and gender-matched sample, 
140 children and adolescents that met DSM-IV criteria for an anxiety disorder other than OCD, 
or for Attention Deficit/Hyperactivity Disorder (ADHD) sensitivity for the MASC, the Anxiety 
Index was 75%, the specificity was 67%, the positive predictive power was 73%, the negative 
predictive power was 69%, the false positive rate was 33%, the false negative rate was 25%, 
kappa was 0.42, and the overall correct classification rate was 71%. While not quite as robust as 
the anxiety/normal comparison, the Anxiety Index thus shows a quite acceptable ability to 
discriminate between children with anxiety and Attention-Deficit/Hyperactivity Disorder. 
A limitation of these studies is the lack of a priori confirmation that the factor structure of 
the MASC is identical in anxious and ADHD youth. Surprisingly, despite considerable attention 
paid to the psychometric problems inherent is discriminating anxiety from ADHD (Conners, 
March, Erhardt, & Butcher, 1995; March, 1998; March & Albano, 1996), there are as yet no 
published confirmatory analytic studies of any self-report anxiety scales in ADHD youth. The 
six-site NIMH collaborative Multimodal Treatment Study of Children with ADHD (MTA) is the 
largest randomized clinical trial ever undertaken in children by the NIMH (Arnold et al., 1997). 
The MTA addresses a priori questions about the individual and combined effects of 
pharmacological and psychosocial (behavioral) treatment for children aged 7 to 10 years with 
ADHD. Among the instruments used in the MTA, the MASC was chosen as the sole self-report 
instrument for assessing anxiety (Hinshaw et al., 1997). The present paper, using confirmatory 
factor analytic methods and baseline pre-treatment data from the MTA sample, reports a 
replication of the four-factor measurement model for the MASC. 
Subjects 
The rationale and design of the MTA have been reported elsewhere (Arnold et al., 1997; 
Hinshaw et al., 1997). Briefly, 579 children aged 7 to 9 years and with DSM-IV ADHD 
(combined type) were selected by using a multiple-gate study entry procedure, after which they 
were randomly assigned to one of the following treatments: medication management, a 
multi-component psychosocial/ behavioral treatment, the combination of medication and 
psychosocial treatment, or community-control assessment-and-referral. The MTA sample is 
representative of the broad range of ADHD youth. Eighty-two percent are male; the mean age is 
8.2 years; and 69% are Caucasian, with the remainder predominately African/American and 
Hispanic/Latino. Approximately 20% are on welfare and 30% are from single-parent families. The 
current report includes pre-treatment baseline data from the entire MTA sample for which the 
MASC was available (n = 571). 
Statistical Methods 
Confirmatory factor analysis (CFA) using full maximum likelihood estimates was 
conducted using SPSS AMOS 3.61 (Arbuckle, 1996). The four MASC factors represent a 
moderately correlated subset of a unitary anxiety factor CFA (March, 1997; March, 1998), which 
argues against the need for statistical independence at the factor level in CFA. Hence, based on 
theoretical considerations, the four main MASC factors were allowed to covary in the final CFA 
model. Item error terms were allowed to covary within but not across the four MASC factors. 
Multiple goodness-of-fit indicators were calculated according to Arbuckle (1996). Because each 
index has different strengths and weaknesses in assessing the goodness-of-fit between a 
hypothetical model and the actual data, multiple indices are generally thought to be necessary to 
adequately evaluate model fit to the data (Arbuckle, 1996; Bentler, 1995) 
Results 
For the four-factor MASC model, the adjusted goodness of fit index (AGFI) was .900, 
the non-normed fit index (NNFI) was 0.910, the comparative fit index (CFI) was 0.918, the 
incremental fit index (IFI) was 0.920 and the RMSEA was .031. As suggested by Bentler (1995), 
values indicating that the model shows excellent fit of the model to the data are AGFI > 0.800, 
NNFI > .900, CFI > .900, the IFI > .900 and RMSEA < 0.05, indicating that the four-factor MASC 
model shows excellent fit to the data in the MTA sample. To allow evaluation of the relative 
importance of each MASC item loading on the four main MASC factors, Table 1 reports 
standardized regression (beta) weights for each item. Additionally, correlation coefficients for 
the four MASC factors in this model fell in the expected range: physical*harm avoidance = 
0.375, social*separation = 0.832, physical*social = 0.772, harm avoidance*separation = 0.645, 
social*harm avoidance = 0.540, physical*separation = 0.829. 
Conclusion 
The overall conclusion gained from this study is that the MASC factor structure replicates 
satisfactorily in a sample of children with ADHD. Indeed, fit indices in this sample are only 
slightly less robust than those in clinical and non-clinical samples that are broadly representative 
of both clinical and normal populations of children and adolescents aged 8 to 18 years. 
Clinically, therefore, this report strengthens confidence that the MASC is a valid measure of 
anxiety in diverse populations, including youth with ADHD. With respect to research, it provides 
supporting evidence that results obtained using the MASC 
MASC 
Item  Factor Estimate 
m01 phys 0.415 
m05 phys 0.447 
m08 phys 0.612 
m12 phys 0.559 
ml5 phys 0.402 
m18 phys 0.495 
m20 phys 0.616 
m24 phys 0.546 
m27 phys 0.471 
m31 phys 0.438 
m35 phys 0.508 
m38 phys 0.472 
m03 soc 0.500 
m10 soc 0.635 
m14 soc 0.580  
m16 soc 0.609 
m22 soc 0.661 
m29 soc 0.523 
m33 soc 0.522 
m37 soc 0.539 
m39 soc 0.449 
m02 HA 0.343 
m06 HA 0.456 
m09 HA 0.345 
m13 HA 0.602 
m21 HA 0.367 
m25 HA 0.529 
m28 HA 0.302 
m32 HA 0.583 
m36 HA 0.501 
m04 sep 0.519 
m07 sep 0.477 
m11 sep 0.387 
m17 sep 0.329 
m19 sep 0.385 
m23 sep 0.308 
m26 sep 0.355 
m30 sep 0.444 
m34 sep 0.526 
Table 1 Standardized regression weights 
in the MTA and other research studies reflect true estimates of anxiety in those samples. In 
addition, replicating the factor structure across ADHD youth buttresses previous work 
demonstrating satisfactory discriminant validity for the MASC relative to normal and ADHD 
youth. 
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